Shin Nippon Biomedical Laboratories Ltd SBLOF
$7.00
Last Updated: Jun 09, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
Shin Nippon Biomedical Laboratories Ltd. Stock Analysis SBLOF
United States Health Care Small Cap Shin Nippon Biomedical Laboratories, Ltd. is a contract research organization providing drug development services including safety research, clinical pharmacology, and clinical trials. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,436 full-time employees. The company went IPO on 2004-03-08. The company operates through four business segments. CRO segment includes non-clinical business using laboratory animals, cells, and bacteria to confirm the efficacy and safety of drugs under development by pharmaceutical companies, and clinical business, conducting trials to confirm efficacy and safety in humans. Translational Research segment develops nasal delivery platform technologies and conducts non-clinical and clinical testing necessary for the evaluation and approval of pharmaceuticals and others. Medipolis segment operates accommodation facilities and geothermal power generation businesses. United States Real Estate segment rents out multi-purpose industrial buildings constructed on sites owned by its subsidiary. The company also undertakes administrative work and provides support for the group's operations.
Shin Nippon Biomedical Laboratories Ltd (SBLOF) Chart
Financial Metrics & Statements of Shin Nippon Biomedical Laboratories Ltd (SBLOF)
FAQ's for Shin Nippon Biomedical Laboratories Ltd (SBLOF)
- As of August 2026, Shin Nippon Biomedical Laboratories Ltd SBLOF is classified as not covered according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Shin Nippon Biomedical Laboratories Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Shin Nippon Biomedical Laboratories Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Shin Nippon Biomedical Laboratories Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Shin Nippon Biomedical Laboratories Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Shin Nippon Biomedical Laboratories Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Shin Nippon Biomedical Laboratories Ltd (SBLOF)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
